Honor recognizes imaging and therapeutic insights behind slowing of brain atrophy
The case for personalized brain mapping in complex disorders
Phase 3 EXPAND trial suggests potential utility of siponimod
Dr. Robert Fox puts a tissue marker study in context
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Paves way for phase 3 testing of novel treatment approach